Obsessive-Compulsive Disorder Clinical Trial
Official title:
Deep-brain Stimulation in Obsessive-compulsive Disorder
A prospective, randomized, double-blinded study was conducted in 7 OCD patients during which 4 electrode contacts along a striatal axis were stimulated bilaterally. DBS electrode implantation followed a trajectory placing contact zero in nucleus accumbens (a common target for OCD treatment) with more proximal contacts placed in striatal segments defined using projections from prefrontal cortex subdivisions (ventromedial, orbitofrontal, dorsolateral) and anterior cingulate cortex.
Patients Seven patients, three men; aged 21-50 years; average (std) 36.67 (±14.64), and four
women; aged 28-46 years; average: 35.25 (±8.14), suffering from treatment-refractory
obsessive compulsive disorder participated in this study. All patients scored 30 or higher in
the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). They were considered as candidates to DBS
for OCD by two independent psychiatrists. An independent psychiatric surgery committee
composed of one neurosurgeon, one psychiatrist and one legal medicine expert agreed surgery
indication was appropriate. All patients provided written informed consent. The study had
approval from the Hospital Clínico San Carlos ethics committee.
Pre-surgical Neuroimaging Before surgery, all patients underwent 3T Siemens TRIO system
(Siemens, Erlangen, Germany) MRI scanning. Patients also performed an OCD symptom provocation
task during fMRI scanning using modified version of the MOCSS (Maudsley Obsessive-Compulsive
Stimuli Set). During scanning, patients were presented with pictures of 4 classes of
provocative stimuli, 50 of each type: 1) contamination/washing, 2) checking, 3) hoarding, 4)
symmetry/order. The study comprised 4 'blocks' pertaining to the 4 classes of provocative
stimuli. Each block consisted of ten 20-s alternating epochs in which subjects viewed either
10 provocative or 10 neutral pictures (see Supplementary material for a full description).
Post-operative computed tomography (CT) scanning was used to determine correct electrode
positioning.
Neurosurgical procedure The target was selected for the distal electrode contact (contact
zero) to be placed at the NAcc close to the bed nucleus of the stria terminalis: 1.5 mm
rostral to the anterior border of the anterior commissure, 4 mm ventral to the AC-PC line and
7 mm lateral to the mid-sagittal plane. Then, the striatum was segmented using the
deterministic DTI projections of the three subdivisions of the prefrontal cortex
(ventromedial vmPFC, orbitofrontal OFC, dorsolateral DLPFC) plus the anterior cingulate
cortex (ACC). A trajectory was planned for placing the rest of the contacts of a Medtronic
Model 3391 stimulating macroelectrode at several points along the striatum avoiding the
ventricles in such a way that each of the electrode contacts (contacts 1, 2, and 3) was
closest to each segment of the striatum corresponding to OFC, DLPFC and ACC.
Deep-Brain Stimulation Protocol After surgery, a random sequence of contact activations (0
[Nacc],1,2 and 3), including sham (-), was generated for each patient. Each contact was
activated using 130 Hz, 60 ms, and 4.5 V for three months (the sham activation was 0 V)
following the patient's individual sequence, separated by one month of washout with the
generator turned off
The study meets a double-blind, longitudinal design. Stimulation contact was set following a
random series known only by the neurosurgeon, with patient, psychiatry and neuropsychology
teams blind. Psychiatric assessment was conducted each month, and neuropsychological testing
was performed after each activation and washout period
Symptom-provocation fMRI analysis Functional imaging data were analyzed using statistical
parametric mapping (SPM12; http://www.fil.ion.ucl.ac.uk/spm) employing an epoch-related
model. The main symptom(s) for each patient was defined and used to construct a contrast of
responses to provocation vs. neutral pictures. The ensuing contrasts were masked with an
inclusive prefrontal mask and the statistical parametric map thresholded at P < 0.001
uncorrected. Cluster extent was defined using AlphaSIM (threshold P < 0.05). Note that due to
weak responses during symptom activation in patients 4 and 6, the SPMs for these patients
were first thresholded at P < 0.01 and 0.005 uncorrected, respectively. After the clinical
protocol had ended, the projections to the cortical activated areas on the MOCSS for each
patient in their main symptomatic dimension from the striatum were calculated using
probabilistic tractography. The connectivity between each of the contacts and the fMRI
activations was calculated as the number of fibers of the projection of each contact (sphere
of diameter 4 mm around the contact) to the cortical activated areas.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04934007 -
Bilateral Lateral OFC rTMS in Obsessive Compulsive Disorder
|
N/A | |
Recruiting |
NCT04071990 -
Family Involvement in CBGT of OCD: a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02541968 -
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Recruiting |
NCT05391503 -
Light Therapy for Obsessive-compulsive Disorder (OCD)
|
N/A | |
Recruiting |
NCT04539951 -
Pragmatic Trial of Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT03416504 -
Methods for Managing Intrusive Thoughts
|
N/A | |
Not yet recruiting |
NCT06029738 -
Effect on Obsessive-Compulsive Beliefs and Symptoms of MCT-OCD
|
N/A | |
Recruiting |
NCT02844049 -
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
|
N/A | |
Terminated |
NCT02909660 -
What Are You Looking for? Psychometric and Experimental Analyses of Reassurance Seeking in Obsessive-compulsive Disorder
|
N/A | |
Completed |
NCT02911324 -
Cannabinoid Medication for Adults With OCD
|
Phase 1/Phase 2 | |
Terminated |
NCT02234011 -
A Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT02217995 -
Mindfulness-Based Cognitive Therapy in a Clinical Sample of OCD Patients
|
N/A | |
Withdrawn |
NCT01953042 -
Benefits of a Psychoeducation Program for Those Awaiting Treatment for OCD and OCD Spectrum Disorders
|
N/A | |
Completed |
NCT02655926 -
Deep Brain Stimulation for Severe Obsessive Compulsive Disorder
|
N/A | |
Completed |
NCT04919785 -
Deep Brain Stimulation in Severe Obsessive-compulsive Disorder
|
N/A | |
Terminated |
NCT00758966 -
Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder
|
Phase 2 | |
Completed |
NCT00742664 -
Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
|
Phase 1/Phase 2 | |
Completed |
NCT00523718 -
Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder
|
Phase 2 | |
Completed |
NCT00074815 -
Treatment of Obsessive Compulsive Disorder in Children
|
Phase 3 |